Logo
x

Search category

Subscribe Now

novocure

Novocure Reports Data from the P-III (METIS) Study of Stereotactic Radiosurgery in NSCLC Patients

Novocure Reports Data from the P-III (METIS) Study of Stereotactic Radiosurgery in NSCLC Patients

  • March 28, 2024
PharmaShots Weekly Snapshots (January 02 - 06, 2023)

PharmaShots Weekly Snapshots (January 02 - 06, 2023)

  • January 6, 2023
Novocure Reports Results from P-III Pivotal Study of Tumor Treating Fields in Non-Small Cell Lung Cancer

Novocure Reports Results from P-III Pivotal Study of Tumor Treating Fields in Non-Small Cell Lung Cancer

  • January 6, 2023
PharmaShots Interview: Novocure's William F. Doyle Shares Insight on Company's Accomplishments in the Treatment of Glioblastoma and Mesothelioma

PharmaShots Interview: Novocure's William F. Doyle Shares Insight on Company's Accomplishments in the Treatment of Glioblastoma an...

  • December 9, 2020
PharmaShots Weekly Snapshot (May 11-15, 2020)

PharmaShots Weekly Snapshot (May 11-15, 2020)

  • May 18, 2020
Novocure and ZaiLab's Optune Receive NMPA's Approval for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

Novocure and ZaiLab's Optune Receive NMPA's Approval for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

  • May 14, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.